This company listing is no longer active
Laboratorio Reig Jofre Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Laboratorio Reig Jofre has a total shareholder equity of €188.5M and total debt of €47.4M, which brings its debt-to-equity ratio to 25.1%. Its total assets and total liabilities are €325.0M and €136.5M respectively. Laboratorio Reig Jofre's EBIT is €9.3M making its interest coverage ratio 14.7. It has cash and short-term investments of €6.0M.
Belangrijke informatie
25.1%
Verhouding schuld/eigen vermogen
€47.40m
Schuld
Rente dekkingsratio | 14.7x |
Contant | €6.04m |
Aandelen | €188.51m |
Totaal verplichtingen | €136.46m |
Totaal activa | €324.98m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: RJF.D's short term assets (€108.8M) exceed its short term liabilities (€74.9M).
Langlopende schulden: RJF.D's short term assets (€108.8M) exceed its long term liabilities (€61.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: RJF.D's net debt to equity ratio (21.9%) is considered satisfactory.
Schuld verminderen: RJF.D's debt to equity ratio has increased from 18.5% to 25.1% over the past 5 years.
Schuldendekking: RJF.D's debt is well covered by operating cash flow (30.6%).
Rentedekking: RJF.D's interest payments on its debt are well covered by EBIT (14.7x coverage).